1. 1) Moriwaki Y, Iizuka T, Nakamura A, Nakata K, Masaoka Y, Ueda T, Koide R, Inatomi M, Fukado Y, Uchida E, Oguchi K, Yasuhara H, Hisamitsu T and Takeshige C : Ocular hypotensive effect of α-adreno-ceptor agonist and antagonist in the conscious pigmented rabbit. Acta Soc Ophthalmol Jpn 96: 152-160 (1992) (in Japanese)
2. 2) Masaoka Y, Nakata K, Ueda T, Koide R, Inatomi M, Fukado Y, Uchida E, Oguchi K and Yasuhara H : Possible mechanism of the ocular hypotensive effect of clonidine in the pigmented rabbit. Acta Soc Ophthalmol Jpn 92: 1503-1509 (1989) (in Japanese)
3. 3) Nakamura T, Nakata K, Masaoka Y, Ueda T, Koide R, Inatomi M, Fukado Y, Uchida E, Oguchi K, Yasuhara H, Hisamitsu T and Takeshige C : Beta blocker induced hypotension via central nervous system. J Eyes (Atarashii Ganka) 6 : 593-596 (1989) (in Japanese)
4. 4) Fukado S, Ueda T, Koide R, Inatomi M, Fukado Y, Oguchi K, Uchida E, Kobayashi S, Yasuhara H, Hisamitsu T and Takeshige C : Central ocular hypotensive effect of apraclonidine in pigmented eye rabbits. J Eyes (Atarashii Ganka) 9 : 865-868 (1992) (in Japanese)
5. 5) Javitt JC and Schiffman RM : Clinical success and quality of life with brimonidine 0.2% or timolol 0.5% used twice daily in glaucoma or ocular hypertension : A randomized clinical trial. Brimonidine Outcomes Study Group 1 J Glaucoma 9 : 224-234 (2000)